130 related articles for article (PubMed ID: 9924854)
1. Angiotensin AT1 receptor inhibition, angiotensin-converting enzyme inhibition, and combination therapy with developing heart failure: cellular mechanisms of action.
Spinale FG; Iannini JP; Mukherjee R; Melton DM; de Gasparo M
J Card Fail; 1998 Dec; 4(4):325-32. PubMed ID: 9924854
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: II. Effects on myocyte contractile processes.
Spinale FG; Mukherjee R; Iannini JP; Whitebread S; Hebbar L; Clair MJ; Melton DM; Cox MH; Thomas PB; de Gasparo M
Circulation; 1997 Oct; 96(7):2397-406. PubMed ID: 9337216
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns.
Krombach RS; Clair MJ; Hendrick JW; Houck WV; Zellner JL; Kribbs SB; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
Cardiovasc Res; 1998 Jun; 38(3):631-45. PubMed ID: 9747431
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: effects on ventricular and myocyte function.
Spinale FG; Holzgrefe HH; Walker JD; Mukherjee R; Kribbs SB; Powell JR; Antonaccio M
J Cardiovasc Pharmacol; 1997 Nov; 30(5):623-31. PubMed ID: 9388045
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibition and angiotensin II subtype-1 receptor blockade during the progression of left ventricular dysfunction: differential effects on myocyte contractile processes.
Spinale FG; Holzgrefe HH; Mukherjee R; Webb ML; Hird RB; Cavallo MJ; Powell JR; Koster WH
J Pharmacol Exp Ther; 1997 Dec; 283(3):1082-94. PubMed ID: 9399980
[TBL] [Abstract][Full Text] [Related]
7. AT1 angiotensin II receptor inhibition in pacing-induced heart failure: effects on left ventricular performance and regional blood flow patterns.
Clair MJ; Krombach RS; Hendrick JW; Houck WV; Hebbar L; Kribbs SB; Rios G; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
J Card Fail; 1998 Dec; 4(4):311-23. PubMed ID: 9924853
[TBL] [Abstract][Full Text] [Related]
8. Effects of combined angiotensin II and endothelin receptor blockade with developing heart failure: effects on left ventricular performance.
New RB; Sampson AC; King MK; Hendrick JW; Clair MJ; McElmurray JH; Mandel J; Mukherjee R; de Gasparo M; Spinale FG
Circulation; 2000 Sep; 102(12):1447-53. PubMed ID: 10993866
[TBL] [Abstract][Full Text] [Related]
9. Myocardial bradykinin following acute angiotensin-converting enzyme inhibition, AT1 receptor blockade, or combined inhibition in congestive heart failure.
Multani MM; Krombach RS; Goldberg AT; King MK; Hendrick JW; Sample JA; Baicu SC; Joffs C; deGasparo M; Spinale FG
J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):369-76. PubMed ID: 11907639
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin AT1 receptor inhibition in pacing induced heart failure: effects on left ventricular myocardial collagen content and composition.
Clair MJ; Krombach RS; Coker ML; Heslin TL; Kribbs SB; de Gasparo M; Spinale FG
J Mol Cell Cardiol; 1998 Nov; 30(11):2355-64. PubMed ID: 9925371
[TBL] [Abstract][Full Text] [Related]
11. Long-term angiotensin-converting enzyme and angiotensin I--receptor inhibition in pacing-induced heart failure: effects on myocardial interstitial bradykinin levels.
Multani MM; Krombach RS; Hendrick JW; Baicu SC; Joffs C; Sample JA; deGasparo M; Spinale FG
J Card Fail; 2001 Dec; 7(4):348-54. PubMed ID: 11782859
[TBL] [Abstract][Full Text] [Related]
12. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure.
Shen YT; Wiedmann RT; Greenland BD; Lynch JJ; Grossman W
Cardiovasc Res; 1998 Aug; 39(2):413-22. PubMed ID: 9798526
[TBL] [Abstract][Full Text] [Related]
13. Direct effects of chronic beta-adrenergic receptor blockade on left ventricular and myocyte function in a model of tachycardia-induced congestive heart failure.
Spinale FG; Johnson WS; Wang Y; Wang Z; Mukherjee R; Hebbar L; Jones BU
J Card Fail; 1996 Dec; 2(4):311-8. PubMed ID: 8989646
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibition and the progression of congestive cardiomyopathy. Effects on left ventricular and myocyte structure and function.
Spinale FG; Holzgrefe HH; Mukherjee R; Hird RB; Walker JD; Arnim-Barker A; Powell JR; Koster WH
Circulation; 1995 Aug; 92(3):562-78. PubMed ID: 7634471
[TBL] [Abstract][Full Text] [Related]
15. Comparison of amlodipine or nifedipine treatment with developing congestive heart failure: effects on myocyte contractility.
McElmurray JH; Mukherjee R; Patterson TM; Goldberg A; King MK; Hendrick JW; Gay DM; Clair MJ; Jolly JR; Spinale FG
J Card Fail; 2001 Jun; 7(2):158-64. PubMed ID: 11420768
[TBL] [Abstract][Full Text] [Related]
16. Selective vasopressin, angiotensin II, or dual receptor blockade with developing congestive heart failure.
Clair MJ; King MK; Goldberg AT; Hendrick JW; Nisato R; Gay DM; Morrison AE; McElmurray JH; Krombach RS; Bond BR; Cazaubon C; Nisato D; Spinale FG
J Pharmacol Exp Ther; 2000 Jun; 293(3):852-60. PubMed ID: 10869385
[TBL] [Abstract][Full Text] [Related]
17. Amlodipine monotherapy, angiotensin-converting enzyme inhibition, and combination therapy with pacing-induced heart failure.
Kribbs SB; Merritt WM; Clair MJ; Krombach RS; Houck WV; Dodd MG; Mukherjee R; Spinale FG
Hypertension; 1998 Mar; 31(3):755-65. PubMed ID: 9495258
[TBL] [Abstract][Full Text] [Related]
18. Effects of ACE inhibitor, AT1 antagonist, and combined treatment in mice with heart failure.
Cavasin MA; Yang XP; Liu YH; Mehta D; Karumanchi R; Bulagannawar M; Carretero OA
J Cardiovasc Pharmacol; 2000 Oct; 36(4):472-80. PubMed ID: 11026648
[TBL] [Abstract][Full Text] [Related]
19. Addition of angiotensin II receptor antagonist to an ACE inhibitor in heart failure improves cardiovascular function by a bradykinin-mediated mechanism.
Koji T; Onishi K; Dohi K; Okamoto R; Tanabe M; Kitamura T; Ito M; Isaka N; Nobori T; Nakano T
J Cardiovasc Pharmacol; 2003 Apr; 41(4):632-9. PubMed ID: 12658066
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic angiotensin-converting enzyme inhibition on left ventricular and myocyte structure and function during recovery from chronic rapid pacing.
Melton DM; Holzgrefe HH; Walker JD; Mukherjee R; Arthur SR; Antonaccio MJ; Koster WH; Spinale FG
J Mol Cell Cardiol; 1997 Feb; 29(2):697-710. PubMed ID: 9140827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
